Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014607
Filing Date
2021-11-04
Accepted
2021-11-04 16:18:02
Documents
93
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lci-20210930x10q.htm   iXBRL 10-Q 1619937
2 EX-31.1 lci-20210930xex31d1.htm EX-31.1 10357
3 EX-31.2 lci-20210930xex31d2.htm EX-31.2 10422
4 EX-32 lci-20210930xex32.htm EX-32 7990
  Complete submission text file 0001558370-21-014607.txt   8466199

Data Files

Seq Description Document Type Size
5 EX-101.SCH lci-20210930.xsd EX-101.SCH 57331
6 EX-101.CAL lci-20210930_cal.xml EX-101.CAL 71054
7 EX-101.DEF lci-20210930_def.xml EX-101.DEF 196749
8 EX-101.LAB lci-20210930_lab.xml EX-101.LAB 587542
9 EX-101.PRE lci-20210930_pre.xml EX-101.PRE 434573
10 EXTRACTED XBRL INSTANCE DOCUMENT lci-20210930x10q_htm.xml XML 1683776
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 211380236
SIC: 2834 Pharmaceutical Preparations